Showing results (401-410 of 514) with videos related to
Sort By:
Pageof 52
Frontiers in Immunology|March 16, 2018
Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or CurdlanMaria Vono, Christiane Sigrid Eberhardt, Elodie Mohr, et al.Plos One|September 9, 2008
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirementsElse Marie Agger, Ida Rosenkrands, Jon Hansen, et al.Elife|May 21, 2014
Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitorsLincoln T Shenje, Peter Andersen, Hideki Uosaki, et al.Journal of Hepatology|February 17, 2016
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasisWendy L van der Woerd, Catharina G K Wichers, Anna L Vestergaard, et al.The Journal of Clinical Investigation|October 21, 2009
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammationSophia Bornstein, Ruth White, Stephen Malkoski, et al.Plos One|September 17, 2009
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxinDavid J M Lewis, Zhiming Huo, Susan Barnett, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA allelesHomayoun Shams, Peter Klucar, Steven E Weis, et al.The Journal of Infectious Diseases|November 20, 2004
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosisT Mark Doherty, Anja W Olsen, Joachim Weischenfeldt, et al.Journal of Biomedical Optics|February 5, 2013
Retinal polarization-sensitive optical coherence tomography at 1060 nm with 350 kHz A-scan rate using an Fourier domain mode locked laserTeresa Torzicky, Sebastian Marschall, Michael Pircher, et al.Vaccine|November 16, 2019
Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal primingCraig P McEntee, Hannah B T Moran, Natalia Muñoz-Wolf, et al.Pageof 52